Financials
- Market Capitalization 1.02 B
- Employee 317
- Founded 2012
- CEO N/A
- Website www.wavelifesciences.com
- Headquarter Delaware, United States
- FIGI BBG0248CHKR2
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2445 | IMMX Immix Biopharma, Inc. - Common Stock | 14.31 USD | +1.71% | +7.03% | +68.95% | +522.17% | 1.02 B USD | ||
| 2446 | ABUS Arbutus Biopharma Corporation - Common Stock | 5.17 USD | -0.39% | -0.58% | +17.23% | +40.49% | 1.02 B USD | ||
| 2460 | ANNX Annexon, Inc. - common stock | 5.25 USD | +5.21% | +0.19% | +5.63% | +147.64% | 995.29 M USD | ||
| 2466 | GERN Geron Corporation - Common Stock | 1.53 USD | 0.00% | -1.92% | +6.25% | +6.25% | 982.98 M USD |
Frequently asked questions about Wave Life Sciences Ltd. Ordinary Shares
What is the Wave Life Sciences Ltd. Ordinary Shares stock price today?
The current price of Wave Life Sciences Ltd. Ordinary Shares (WVE) is 5.16. Over the past 24 hours, the stock has changed by -1.34%. Follow the WVE chart for real-time price dynamics.
What is the stock ticker of Wave Life Sciences Ltd. Ordinary Shares?
Wave Life Sciences Ltd. Ordinary Shares trades under the ticker WVE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Wave Life Sciences Ltd. Ordinary Shares stock going up?
WVE has changed by -2.82% over the last week, -11.64% over the last month, and -27.93% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Wave Life Sciences Ltd. Ordinary Shares?
Wave Life Sciences Ltd. Ordinary Shares currently has a market capitalization of 1.02 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Wave Life Sciences Ltd. Ordinary Shares earnings last quarter?
Last quarter, Wave Life Sciences Ltd. Ordinary Shares reported earnings of -0.34 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Wave Life Sciences Ltd. Ordinary Shares revenue for the last quarter?
Wave Life Sciences Ltd. Ordinary Shares reported quarterly revenue of 2.27 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Wave Life Sciences Ltd. Ordinary Shares net income for the last quarter?
Wave Life Sciences Ltd. Ordinary Shares reported net income of -69.36 M for the last quarter. The previous quarter showed -26.09 M, which means net income changed by -165.86%.
How many employees does Wave Life Sciences Ltd. Ordinary Shares have?
As of the latest available data, Wave Life Sciences Ltd. Ordinary Shares has 317 employees. Workforce size can provide additional context about the company's scale and operations.
What is Wave Life Sciences Ltd. Ordinary Shares EBITDA?
Wave Life Sciences Ltd. Ordinary Shares EBITDA is -72.94 M, and its EBITDA margin is -3 210.56%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Wave Life Sciences Ltd. Ordinary Shares stock?
You can buy Wave Life Sciences Ltd. Ordinary Shares (WVE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Wave Life Sciences Ltd. Ordinary Shares stock?
Investing in Wave Life Sciences Ltd. Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the WVE chart and related analysis on metatrader.com as part of your research.